Infinium Global Research has added a new report on Global Antiviral Drugs Market: Trends Analysis and Forecast 2023. The report presents analysis global as well as regional markets of antiviral drugs over the period of 2017 to 2023. Moreover, the IGR-Growth Matrix given in the report provides key focus areas and investment areas the market players can focus on. The market size is presented in terms of value for the historic year 2015 and estimated for forecast period of 2017 to 2023.
Get 15% discount for early purchase of “Global Antiviral Drugs Market by region (North America, Europe, Asia Pacific, and RoW)” report on
The global antiviral drugs market was dominated by the North America region followed by the Europe antiviral drugs market with potential growth in both of this region, whereas Asia Pacific anticipated growing at highest CAGR. Based on the countries US is the major market for antiviral drugs globally followed by India, Germany, and UK.Moreover, India has most HIV cases due which it is one of the most dynamic markets worldwide followed by US at second place.Increasing incidences of epidemics in viral infections has played vital role and predominantly drives global antiviral drugs market.Furthermore, strong research and development activities in order to develop and introduce advanced drugs and advanced treatment and formulations including vaccines and combination therapy and others have encouraged demand for antiviral drugs.
Regionally,North America is the largest and dominated market globally and it is anticipated to retain its dominance by accounting largest market shares during forecast period of 2017 to 2023. The growth in this region can be credible to sophisticated healthcare infrastructure as well as presence of leading market players in this region. Whereas, Asia Pacific region expected to emerge as most dynamic region with highest CAGR during forecast period.This is due to Indian market contribution in the region growth followed by China and South Korea. The report covers the analysis of global as well as regional markets of the antiviral drugs market. Moreover the report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand globally as well as regionally. Moreover, Infinium Global Research- Growth Matrix (IGR- Growth Matrix) given in the report brings an insight on the investment areas that existing or new market players can consider.
The report provides insights into the market using analytical tools such as Porter’s five forces analysis and value chain analysis of antiviral drugs. Moreover, the study highlights current market trends and provides forecast from 2017 to 2023. We also have highlighted future trends in the antiviral drugs that will impact the demand during the forecast period.
The Infinium Global Research- Growth Matrix (IGR- Growth Matrix) provided in this report highlights key investing markets in the world. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market. This report will help manufacturers, suppliers and distributors to understand the present and future trends in this market and formulate their strategies accordingly.
The companies covered in the report include Roche Holding AG, Gilead, GlaxoSmithKline, Bristol-Myers-Squibb, Abbott Healthcare, Med Immune/AstraZeneca, Schering-Plough, Johnson & Johnson, Merck & Co, Gilead Sciences, Dr Reddy, and Cipla
Reasons to buy this report
1) Comprehensive analysis of global as well as regional markets of Antiviral Drugs.
2) Complete coverage of all the type, form, processing, and application segments to analyze the trends, developments, and forecast of market size up to 2023.
3) Comprehensive analysis of the companies operating in this market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4) Infinium Global Research- Growth Matrix presents analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.
About Infinium Global Research
Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.
Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.